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A B S T R A C T
Aim: Epilepsy is one of the most common neurologic problems worldwide. A relationship between
epilepsy and hormones has been demonstrated. This study was designed to investigate the effect of
seizure on blood ghrelin level.
Methods: Twenty male Wistar rats were divided into two groups. The control group received saline and
the pentylenetetrazole (PTZ) group received a single convulsive dose (50 mg/kg) of PTZ. Thirty minutes
later blood samples were collected and acylated and unacylated ghrelin levels in the plasma were
assayed.
Results: Acylated or active form of ghrelin decreased signiﬁcantly (p < 0.05) after a PTZ-induced seizure,
but the reduction of unacylated and total blood ghrelin levels failed to reach statistical signiﬁcance.
Conclusion: These ﬁndings may reﬂect that PTZ-induced epilepsy decreases AG of plasma.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is one of the most common neurologic problems
worldwide1 and characterized by recurrent unprovoked seizures.2
The relationship between epilepsy and the endocrine system has
been investigated by neurologists, endocrinologists, and basic
scientists.3 Some studies have suggested a relationship between
epilepsy and GH, sex hormones, the NPY system, nesfatin-1,
ghrelin, and chromogranin A.4 It is also reported that mean daily
blood concentrations of ACTH, cortisol and beta-endorphin in
patients with epilepsy are higher in comparison with those of the
healthy volunteers.5
Ghrelin is a 28-amino acidmotilin-related peptide. The peptide is
characterized by the presence of an n-octanoylation on the hydroxy
group of serine in position 3.6 The octanoylated peptide hormone is
producedandsecretedbyA-likecellswithin theoxynticglandsof the
stomach.7 Ghrelin circulates in the bloodstream in twomajor forms:
acylated (AG; or n-octanoylated) and unacylated (UAG; or deso-
ctanoylated or desacylated).8 Acylation is a post-transcriptional
modiﬁcation that is essential for binding to the growth hormone
secretagogue receptor (GHS-R) to a point that ghrelin is originally
supposed to be biologically active only in acylated form.6 The
acyltransferase that catalyzes ghrelin octanoylation has recently
been identiﬁed as ghrelin O-acyltransferase (GOAT).9* Corresponding author at: Dept of Physiology, Faculty of Medicine, Tabriz
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doi:10.1016/j.seizure.2011.01.001Ghrelin exerts neuroendocrine effects of eliciting growth
hormone release, regulating appetite and energy metabolism,
and carries many other functions in a variety of tissues and organs
such as gastroenteropancreatic, cardiovascular, reproduction, and
immune systems.10 A deﬁnite relationship between ghrelin and
seizure has also been demonstrated in animals and humans,
although the results are controversial.4 Some research has
suggested that serum ghrelin levels are enhanced in patients with
epilepsy11 and in prepubertal epileptic children treated with
valproic acid (VPA).12 On the other hand, some studies have shown
that ghrelin levels decreased in epileptic adults13 and normal-
weight prepubertal children14 taking VPA treatment. In addition,
Aydin et al. reported that serum and saliva ghrelin levels were
lower in epileptic patients before treatment than in controls.2 To
clarify these controversies, evaluation of blood ghrelin levels
immediately after induced epileptic seizures in animals is
beneﬁciary.
Therefore, the purposes of this study were: (1) to determine AG
and UAG levels in blood samples from pentylenetetrazole (PTZ)-
induced epileptic rats using an enzyme-linked immunosorbent
assay (ELISA); (2) to determine any association between ghrelin
and epilepsy and clarify the controversial results reported for this
hormone.
2. Materials and methods
2.1. Chemicals and instruments
PTZ was purchased from Tocris Bioscience, UK (Bristol). Blood
AG andUAG levelswere determined by ELISA using an ELISA readervier Ltd. All rights reserved.
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Fig. 2. Effect of PTZ (i.p.) induced seizure on unacylated blood ghrelin (pg/mL) level.
Data are expressed as mean  standard error of the mean (SEM). n = 10 animals per
group.
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Fig. 3. Effect of PTZ (i.p.) induced seizure on total blood ghrelin (pg/mL) level. Data
are expressed as mean  standard error of the mean (SEM). n = 10 animals per group.
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394062400R and Cat. No. RD394063400R, Biovendor co, Czech
Republic).
2.2. Animals
All experimental procedures were approved by the Regional
Ethics Committee of Tabriz University of Medical Sciences. The
experiments were performed on male Wistar rats (220–260 g)
with food and water available ad libitum, except during the 30 min
of procedure. Animals were maintained under controlled temper-
ature (21–23 8C) and light (12 h light, 12 h dark) and with a
humidity of 5–10%. All the experimental procedures were carried
out between 08.00 and 10.00 a.m.
2.3. Experimental design
Twenty rats were divided into two groups: control (n = 10) and
PTZ (n = 10). The PTZ group received a single convulsive dose
(50 mg/kg) of PTZ and the control group received the same volume
of saline, intraperitoneally (i.p.). Seizures were elicited in all PTZ-
receiving rats. After 30 min of the injections, blood samples were
taken from the animals’ heart and collected in tubes containing
EDTA and p-hydroxymercuribenzoic acid (1 mM in the ﬁnal
sample volume) to prevent the degradation of AG by protease.
Samples were immediately centrifuged at 3500 rpm for 10 min at
+4 8C and then, the plasma was transferred into separate tubes.
Samples were immediately assayed.
2.4. Statistical analysis
SPSS 13.0 software was used for statistical comparisons of data,
and data expressed as the means  SEM. Differences in AG, UAG and
total ghrelin levels between the groups were analyzed by indepen-
dent Student’s t-test (one- or two-tailed) and p < 0.05 was accepted
as signiﬁcant.
3. Results
As shown in Fig. 1, an independent Student’s t-test indicated
that AG levels of blood decreased signiﬁcantly (p < 0.05) after i.p.
injection of PTZ, compared to saline groups.
Figs. 2 and 3 illustrate the effect of PTZ-induced seizure on UAG
and total ghrelin levels of blood, respectively. Independent
Student’s t-tests indicated that UAG and total ghrelin levels of[()TD$FIG]
Fig. 1. Effect of PTZ (i.p.) induced seizure on acylated blood ghrelin (pg/mL) level.
Data are expressed as mean  standard error of the mean (SEM). n = 10 animals per
group. *p < 0.05 compared with the control group.blood did not change signiﬁcantly with respect to control group.
AG/UAG ratio also was not modiﬁed by PTZ-induced seizures.
4. Discussion
To our knowledge, this is the ﬁrst study to examine blood
ghrelin levels in PTZ-induced seizures in rats. The results of this
study showed that active form or acylated blood ghrelin levels
decreased signiﬁcantly after PTZ-induced seizures. UAG and total
blood ghrelin levels also decreased although they failed to reach
statistical signiﬁcance. The results for the blood ghrelin response to
the PTZ-induced seizure showed that measuring the concentration
of ghrelin is a useful method for studying plasma ghrelin changes
over short time.
In recent years, many researchers have focused on the
relationships between epilepsy and the endocrine system since
epileptic seizures are related to the temporary changes in hormone
secretion.2 A deﬁnite relationship between ghrelin and seizures
has been already demonstrated in animals and humans, although
the results are controversial.
Some authors have demonstrated that ghrelin levels were
increased in children treated with VPA in comparison to healthy
controls.12,15 Berilgen et al. also reported that serum ghrelin levels
were higher in epilepsy patients who received antiepileptic drug
therapy than a control group.11
Contradictorily, circulating ghrelin levels were signiﬁcantly
lower in epileptic patients treated with VPA in pubertal13 and
prepubertal periods.14,16 Some studies also showed that both
acylated and deacylated forms of serum and salivary ghrelin were
depressed in epileptic patients before and after speciﬁc treatment
with respect to normal controls.2,4
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ghrelin level of blood decreases with epilepsy. In addition our
results showed that AG decreased signiﬁcantly but the reduction of
UAG and total levels were not signiﬁcant. Two possibilities may be
considered in this regard: (1) ghrelin is reduced by a feed back
system or (2) uptake of AG is increased by CNS structures to
modulate epileptic discharges.
In accordance with the ﬁrst possibility, some hormones can
reduce the production, acylation or secretion of ghrelin such as
somatostatin and leptin.
Somatostatin, a peptide produced in the brain, gastrointestinal
tract, and pancreas, exerts a broad spectrum of biological activities
throughparacrine, endocrine, andneuroendocrinemechanisms.17 It
is preferentially released fromneurons under conditions of elevated
activity (i.e. bursting or high frequency neuronal activation), e.g.
during seizures.18 It is also previously reported that a single
intravenous injection of somatostatin reduces the systemic plasma
concentration of ghrelin in rats17 and human healthy volunteers.19
In addition, somatostatin decreases GOAT expression,20 enzyme
which catalyzes acylation of ghrelin.9 Therefore, it is possible that
blood AG reduction is due to somatostatin released from one of its
sources during PTZ-induced seizure. Moreover, a faster rebound of
UAG level respect to AG (due to inhibitory effect of somatostatin on
GOAT expression) may be occurred.
Some studies suggest that kindled seizures induce high serum
leptin levels in rats.21,22 In this context, kindled female rats had
leptin levels approximately twice as high as the controls during
diestrus phase.22 On the other hand, ghrelin is negatively regulated
by leptin23 and physiological concentrations of leptin and a
moderate hyperleptinemia directly inhibit ghrelin secretion from
the isolated perfused rat stomach.24 Therefore, ghrelin reduction
might be due to release of leptin during PTZ-induced seizure.
In a discussion of the second possibility, human ghrelin exhibits
saturable binding and endocytosis in the RBE4 rat cerebral
microvessel endothelial cell line.25 On the other hand, blood brain
barrier mechanisms regulating ghrelin accumulation by brain may
be inﬂuenced by pathophysiological events.26 It has also been
shown that ghrelin or its agonists can be considered as an anti-
epileptic agent in rodents.27,28 Therefore, reduction of plasma AG
after PTZ-induced seizure could be attributed to its uptake by brain
to represent an anti-epileptic effect. In this mater, evaluation of
brain ghrelin levels immediately after induced epileptic seizures in
animals is beneﬁciary.
Finally, proteolysis of AG29 and degradation into non-UAG
metabolites30 could be occurred during seizures.
In conclusion, the results obtained from our study showed that
AG decreased signiﬁcantly in blood after PTZ-induced seizures. In
the future, a better understanding of the mechanisms responsible
for seizure-induced alterations in hormone levels of plasma may
help to prevent these changes.
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